Clinical Trial

Safety and Feasibility of the CorVad Percutaneous Ventricular Assist System in Refractory Right Heart Failure

Name: Safety and Feasibility of the CorVad Percutaneous Ventricular Assist System in Refractory Right Heart Failure — clinical trial record (NCT07704424)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to evaluate the safety and feasibility of the CorVad Percutaneous Ventricular Assist System (Device model: CorVad RS) in patients with right heart failure who continue to experience hemodynamic instability despite best medical therapy.

Trial Details

NCT Number	NCT07704424
Lead Sponsor	Shenzhen Core Medical Technology CO.,LTD.
Conditions	Right Heart Failure
Enrollment	6 participants
Start Date	2026-06-02
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-07-15